作者: Johannes Rieber , Philip Jung , Thomas M. Schiele , Andreas Koenig , Isabelle Erhard
DOI: 10.1007/S00392-002-1321-1
关键词: Cost effectiveness 、 Internal medicine 、 Conventional PCI 、 Survival analysis 、 Balloon 、 Treatment strategy 、 Medicine 、 Breast cancer 、 Fractional flow reserve 、 Angioplasty 、 Cardiology
摘要: Fractional flow reserve (FFR) as a new technique for physiological assessment of coronary stenoses could identify patients with CAD in whom the deferral an intended PCI was more beneficial than performing planned procedure. It is up to now unknown whether FFR-based therapy stratification also safe multivessel disease and complex lesions. This study demonstrates 71 symptomatic predominantly angiographically intermediate lesions that do not benefit from procedures terms overall survival, target vessel patency or clinical symptoms during 12 month follow-up if FFR above 0.75.